Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia
- 28 February 2006
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (3), 295-309
- https://doi.org/10.1016/j.ejca.2005.09.017
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Efflux Kinetics and Intracellular Distribution of Daunorubicin Are Not Affected by Major Vault Protein/Lung Resistance-Related Protein (Vault) ExpressionCancer Research, 2004
- Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1Gene Therapy, 2004
- Structure–Activity Studies of Verapamil Analogs That Modulate Transport of Leukotriene C4 and Reduced Glutathione by Multidrug Resistance Protein MRP1Biochemical and Biophysical Research Communications, 2000
- MDR1 mRNA Expression In Young Patients With Acute Lymphoblastic LeukaemiaBritish Journal of Haematology, 2000
- The Leukotriene LTD4 Receptor Antagonist Mk571 Specifically Modulates MRP Associated Multidrug ResistanceBiochemical and Biophysical Research Communications, 1995
- Differential modulation of P-glycoprotein transport by protein kinase inhibitionBiochemistry, 1993
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- ABC Transporters: From Microorganisms to ManAnnual Review of Cell Biology, 1992
- Detection of multidrug-resistant protein, P-glycoprotein in childhood leukaemia and lymphomaEuropean Journal of Pediatrics, 1991
- Failure to detect the P-glycoprotein multidrug resistant phenotype in cases of resistant childhood acute lymphocytic leukaemiaEuropean Journal of Cancer and Clinical Oncology, 1989